Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of generic rosuvastatin + ezetimibe 20/10 mg vs EZUVAS in healthy Thai volunteers (fasting)
TCTR20260527013Phase 1Not yet recruiting
- Sponsor
- International Bio Service
- Start
- Sep 2026
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of rosuvastatin and ezetimibe in hypercholesterolemia (2 arms), sponsored by International Bio Service. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
rosuvastatinezetimibe
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on TCTR20260527013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260527013.